Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center.
Pellegrino F, Leni R, Basile G, Rosiello G, Re C, Scilipoti P, De Angelis M, Longoni M, Avesani G, Quarta L, Zaurito P, Cattafi F, Burgio G, Gandaglia G, Montorsi F, Briganti A, Moschini M. Pellegrino F, et al. Among authors: quarta l. World J Urol. 2024 Apr 28;42(1):270. doi: 10.1007/s00345-024-04970-x. World J Urol. 2024. PMID: 38679650
Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score.
Pellegrino F, Stabile A, Sorce G, Quarta L, Robesti D, Cannoletta D, Cirulli G, Barletta F, Scuderi S, Mazzone E, de Angelis M, Brembilla G, De Cobelli F, Salonia A, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: quarta l. Eur Urol Focus. 2023 Oct 19:S2405-4569(23)00223-7. doi: 10.1016/j.euf.2023.10.006. Online ahead of print. Eur Urol Focus. 2023. PMID: 37865591
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
Pellegrino F, Stabile A, Sorce G, Mazzone E, Cannoletta D, Cirulli GO, Quarta L, Leni R, Robesti D, Brembilla G, Gandaglia G, De Cobelli F, Montorsi F, Briganti A. Pellegrino F, et al. Among authors: quarta l. Prostate. 2024 Apr;84(5):473-478. doi: 10.1002/pros.24665. Epub 2023 Dec 27. Prostate. 2024. PMID: 38149793
Long-term functional outcomes after robot-assisted radical cystectomy with intracorporeal ileal orthotopic neobladder.
Pellegrino F, Scilipoti P, Rosiello G, Longoni M, Leni R, Basile G, Quarta L, Zaurito P, Re C, de Angelis M, Cattafi F, Burgio G, Gandaglia G, Montorsi F, Briganti A, Moschini M. Pellegrino F, et al. Among authors: quarta l. BJU Int. 2024 Jul;134(1):48-50. doi: 10.1111/bju.16337. Epub 2024 Mar 14. BJU Int. 2024. PMID: 38482772 No abstract available.
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.
Longoni M, Scilipoti P, Re C, Rosiello G, Nocera L, Pellegrino F, Basile G, de Angelis M, Quarta L, Burgio G, Necchi A, Cigliola A, Chiti A, Picchio M, Salonia A, Briganti A, Montorsi F, Moschini M. Longoni M, et al. Among authors: quarta l. BJU Int. 2024 Oct;134(4):636-643. doi: 10.1111/bju.16363. Epub 2024 Apr 15. BJU Int. 2024. PMID: 38621771
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study.
Quarta L, Mazzone E, Cannoletta D, Stabile A, Scuderi S, Barletta F, Cucchiara V, Nocera L, Pellegrino A, Robesti D, Leni R, Zaurito P, Brembilla G, De Cobelli F, Samanes Gajate AM, Picchio M, Chiti A, Montorsi F, Briganti A, Gandaglia G. Quarta L, et al. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3789-3798. doi: 10.1007/s00259-024-06789-5. Epub 2024 Jun 11. Eur J Nucl Med Mol Imaging. 2024. PMID: 38861182 Free PMC article. Clinical Trial.
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study.
Leni R, Vertosick EA, van den Bergh RCN, Soeterik TFW, Heetman JG, van Melick HHE, Roscigno M, La Croce G, Da Pozzo LF, Olivier J, Zattoni F, Facco M, Dal Moro F, Chiu PKF, Wu X, Heidegger I, Giannini G, Bianchi L, Lampariello L, Quarta L, Salonia A, Montorsi F, Briganti A, Capitanio U, Carlsson SV, Vickers AJ, Gandaglia G; EAU-YAU Prostate Cancer Working Group. Leni R, et al. Among authors: quarta l. Eur Urol Open Sci. 2024 Aug 20;68:10-17. doi: 10.1016/j.euros.2024.08.004. eCollection 2024 Oct. Eur Urol Open Sci. 2024. PMID: 39257622 Free PMC article.
54 results